Keystone eSymposia Logo

Cancer Stem Cells: Advances in Biology and Clinical Translation

May 19-21, 2021 | 8:00AM EDT | 12:00PM UTC | 2:00PM CEST*
*Program is in development and subject to change


  Register    Tweet This


 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Preponderant experimental and clinical evidence has demonstrated that pervasive cancer cell heterogeneity in both phenotypic presentations and functional properties exists, such that a population of cancer cells with cardinal stem cell properties (i.e., cancer stem cells) pre-exists in untreated tumors and spatiotemporally evolves during tumor progression and therapeutic interventions. Recent studies have also revealed significant phenotypic and functional plasticity in cancer cells, regulated by both genetic networks and epigenetic mechanisms. Both cancer cell heterogeneity and plasticity constitute major barriers to effective and durable clinical treatments. 

Ever since the revival of the cancer stem cell research field in the last two decades, we have made great strides in identifying and elucidating the biology of cancer stem cells in virtually all tumor systems. Significant progress has also been made in understanding how cancer stem cells interact with the cellular constituents and soluble factors in the proinflammatory and immune-suppressive tumor microenvironment. Facilitated by an explosion of technical advances in recent years, especially single-cell RNA-seq, we are achieving an unprecedented appreciation of the complexity of the cellular heterogeneity of human tumors. Significantly, novel therapeutic strategies that target cancer stem cells and cancer cell heterogeneity and plasticity are rapidly progressing to the clinical arena. 

This conference is organized to recapitulate these recent advances in our understanding of cancer stem cell biology and, importantly, the clinical translation of targeting cancer stem cells.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: April 7, 2021
‣ For Poster Booth: May 4, 2021
ePoster / SciTalk Submission: May 7, 2021
Financial Aid Application: May 4, 2021

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSStemCell21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Speaking at this eSymposia


Anna Dubrovska

University Hospital Carl Gustav Carus, Germany


Markus Grompe

Oregon Health & Science University, USA


Wei Guo

University of Pennsylvania, USA


Junfang Ji

Zhejiang University, China


Klaus H. Kaestner

University of Pennsylvania School of Medicine, USA


Calvin Kuo

Stanford University, USA


Justin D. Lathia

Cleveland Clinic, USA


Stephanie K.Y. Ma

University of Hong Kong, Hong Kong


Jos J. Melenhorst

University of Pennsylvania, USA


Irene Oi Lin Ng

University of Hong Kong, Hong Kong


Duanqing Pei

Guangzhou Institutes of Biomedicine and Health, China


Lola McAdams Reid

University of North Carolina at Chapel Hill, USA


Clemens A. Schmitt

Max Delbrück Center for Molecular Medicine, Germany


Michael M. Shen

Columbia University, USA


Erwei Song

Sun-Yat-Sen Memorial Hospital, China


Dean G. Tang

Roswell Park Cancer Institute, USA


Xin Wei Wang

NCI, National Institutes of Health, USA


Irving L. Weissman

Stanford University, USA


Richard White

Memorial Sloan Kettering Cancer Center, USA


Wolf Ruprecht Wiedemeyer

AbbVie, Inc., USA


Carmen Chak-Lui Wong

University of Hong Kong, Hong Kong


Chunzhang Yang

NCI, National Institutes of Health, USA


Ning Zhang

Peking University, China




Sponsors


 

sponsor-carousel-cellpress.png

 




Additional Support



sponsor-carousel-bmgf.png

sponsor-carousel-nci.png

Funding for this conference was made possible (in part) by 1R13CA261003-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

 

sponsor-carousel-scientist.png

 





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia



Tags: